The restructuring of dopamine receptor subtype gene transcripts in c-fos KO mice

Brain Research Bulletin

Volumn 87, Issue 6, 2012, Pages 511-520

  Benes, Jan ^a   Mravec, Boris ^b,d   Krizanova, Olga ^c   Kvetnansky, Richard ^d   Myslivecek, Jaromir ^a,e  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Bratislava   (Slovakia)

^c INSTITUTE OF MOLECULAR PHYSIOLOGY AND GENETICS   (Slovakia)

^d INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

^e TECHNICAL UNIVERSITY OF LIBEREC   (Czech Republic)

Author keywords

C fos; Cerebellum; Cerebral cortex; Dopamine receptors; Hippocampus; Hypothalamus; Striatum

Indexed keywords

ACETYLCHOLINESTERASE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE RECEPTOR; MESSENGER RNA; PROTEIN C FOS;

ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; CEREBELLUM CORTEX; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; FEMALE; FRONTAL CORTEX; GENE EXPRESSION; GENETIC TRANSCRIPTION; HYPOTHALAMUS; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PARIETAL CORTEX; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TEMPORAL CORTEX; WILD TYPE;

ACETYLCHOLINESTERASE; ANIMALS; BENZAZEPINES; BRAIN; BRAIN MAPPING; DOPAMINE ANTAGONISTS; FEMALE; GENE EXPRESSION REGULATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTORS, DOPAMINE; RNA, MESSENGER; SEX FACTORS; SPIPERONE; TRITIUM;

EID: 84859158438     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2012.02.006     Document Type: Article

References (42)

1. Adencreutz M., Hau J. Gender and cognitive aspects of neonatal and juvenile neuromuscular locomotor development of F1 hybrid mice in swim tests. Laboratory Animals 2008, 42:26-33.
2. Becker J.B. Gender differences in dopaminergic function in striatum and nucleus accumbens. Pharmacology Biochemistry and Behavior 1999, 64:803-812.
3. Billy T.C., Hopf F.W., Antonello B. Synaptic plasticity in the mesolimbic system. Annals of the New York Academy of Sciences 2010, 1187:129-139.
4. Dampney R.A.L., Horiuchi J. Functional organisation of central cardiovascular pathways: studies using c-fos gene expression. Progress in Neurobiology 2003, 71:359-384.
5. Deng X., Ladenheim B., Tsao L.-I., Cadet J.L. Null mutation of c-fos causes exacerbation of methamphetamine-induced neurotoxicity. The Journal of Neuroscience 1999, 19:10107-10115.
6. T.F.o.t.E.S.o.C.t.N.A.S.o.P.Electrophysiology Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation 1996, 93:1043-1065.
7. Fleischmann A., Hafezi F., Elliott C., Remé C.E., Rüther U., Wagner E.F. Fra-1 replaces c-Fos-dependent functions in mice. Genes & Development 2000, 14:2695-2700.
8. Fleischmann A., Hvalby O., Jensen V., Strekalova T., Zacher C., Layer L.E., Kvello A., Reschke M., Spanagel R., Sprengel R., Wagner E.F., Gass P. Impaired long-term memory and NR2A-Type NMDA receptor-dependent synaptic plasticity in mice lacking c-Fos in the CNS. The Journal of Neuroscience 2003, 23:9116-9122.
9. Galvis-Alonso O.Y., Garcia A.M.B., Orejarena M.J., Lamprea M.R., Botelho S., Conde C.A., Morato S., Garcia-Cairasco N. A combined study of behavior and Fos expression in limbic structures after re-testing Wistar rats in the elevated plus-maze. Brain Research Bulletin 2010, 81:595-599.
10. Gerald T., Howlett A., Ward G., Ho C., Franklin S. Gene expression of opioid and dopamine systems in mouse striatum: effects of CB1 receptors, age and sex. Psychopharmacology 2008, 198:497-508.
11. Girault J.-A., Greengard P. The neurobiology of dopamine signaling. Archives of Neurology 2004, 61:641-644.
12. Gross J., Andersson K., Chen Y., Müller I., Andreeva N., Herrera-Marschitz M. Effect of perinatal asphyxia on tyrosine hydroxylase and D2 and D1 dopamine receptor mRNA levels expressed during early postnatal development in rat brain. Molecular Brain Research 2005, 134:275-281.
13. Herdegen T., Leah J.D. Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Research and Brain Research Reviews 1998, 28:370-490.
14. Hrabovska A., Farar V., Bernard V., Duysen E.G., Brabec J., Lockridge O., Myslivecek J. Drastic decrease in dopamine receptor levels in the striatum of acetylcholinesterase knock-out mouse. Chemico-Biological Interactions 2010, 183:194-201.
15. Hruska R.E., Ludmer L.M., Pitman K.T., De Ryck M., Silbergeld E.K. Effects of estrogen on striatal dopamine receptor function in male and female rats. Pharmacology, Biochemistry, and Behavior 1982, 16:285-291.
16. Hughes P., Dragunow M. Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacological Reviews 1995, 47:133-178.
17. Hurd Y.L., Svensson P., Pontén M. The role of dopamine, dynorphin, and CART systems in the ventral striatum and amygdala in cocaine abuse. Annals of the New York Academy of Sciences 1999, 877:499-506.
18. Chang H.Y., Mitzner W. Sex differences in mouse models of asthma. Canadian Journal of Physiology and Pharmacology 2007, 85:1226-1235.
19. Chen X., Grisham W., P.Arnold A. X chromosome number causes sex differences in gene expression in adult mouse striatum. European Journal of Neuroscience 2009, 29:768-776.
20. Chocyk A., Czyrak A., Wedzony K. Dopamine D1-like receptors agonist SKF 38393 increases cFOS expression in the paraventricular nucleus of the hypothalamus - impact of acute and chronic cocaine. Journal of Physiology and Pharmacology 2008, 59:425-440.
21. Johnson R.S., Spiegelman B.M., Papaioannou V. Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Cell 1992, 71:577-586.
22. Jochum W., Passegue E., Wagner E.F. AP-1 in mouse development and tumorigenesis. Oncogene 2001, 20:2401-2412.
23. Kawashima K., Yoshikawa K., Fujii Y.X., Moriwaki Y., Misawa H. Expression and function of genes encoding cholinergic components in murine immune cells. Life Sciences 2007, 80:2314-2319.
24. Kim K.W., Kim H.W., Li J., Kwon Y.B. Effect of bee venom acupuncture on methamphetamine-induced hyperactivity, hyperthermia and Fos expression in mice. Brain Research Bulletin 2011, 84:61-68.
25. Kovács K.J. Invited review c-Fos as a transcription factor: a stressful (re)view from a functional map. Neurochemistry International 1998, 33:287-297.
26. Largo R.H., Fischer J.E., Rousson V. Neuromotor development from kindergarten age to adolescence: developmental course and variability. Swiss Medical Weekly 2003, 133:193-199.
27. Lemmer K., Ahnert-Hilger G., Hopfner M., Hoegerle S., Faiss S., Grabowski P., Jockers-Scherubl M., Riecken E.O., Zeitz M., Scherubl H. Expression of dopamine receptors and transporter in neuroendocrine gastrointestinal tumor cells. Life Sciences 2002, 71:667-678.
28. Lévesque D., Di Paolo T. Rapid conversion of high into low striatal D2-dopamine receptor agonist binding states after an acute physiological dose of 17[beta]-estradiol. Neuroscience Letters 1988, 88:113-118.
29. Li B., Stribley J.A., Ticu A., Xie W., Schopfer L.M., Hammond P., Brimijoin S., Hinrichs S.H., Lockridge O. Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse. Journal of Neurochemistry 2000, 75:1320-1331.
30. Myslivecek J., Barcal J., Hassmannova J., Zahlava J., Zalud V. Interactions between nitric oxide and dopamine in inhibitory learning and memory in newborn rats. Neuroscience 1997, 79:659-669.
31. Pacak K., Palkovits M. Stressor specificity of central neuroendocrine responses: implications for stress-related disorders. Endocrine Reviews 2001, 22:502-548.
32. Pennypacker K.R., Hong J.-S., McMillian M.K. Implications of prolonged expression of Fos-related antigens. Trends in Pharmacological Sciences 1995, 16:317-321.
33. Ren-Patterson R., Cochran L., Holmes A., Lesch K.-P., Lu B., Murphy D. Gender-dependent modulation of brain monoamines and anxiety-like behaviors in mice with genetic serotonin transporter and BDNF deficiencies. Cellular and Molecular Neurobiology 2006, 26:753-778.
34. Shearman L.P., Weaver D.R. Haloperidol regulates neurotensin gene expression in striatum of c-fos-deficient mice. Molecular Brain Research 1997, 47:275-285.
35. Shiromani P.J., Basheer R., Thakkar J., Wagner D., Greco M.A., Charness M.E. Sleep and wakefulness in c-fos and fos B gene knockout mice. Molecular Brain Research 2000, 80:75-87.
36. Tomankova H., Myslivecek J. Mechanisms of G protein-coupled receptors regulation. Neuroendocrinology Letters 2011, 32:607-615.
37. Wagner E.F. Functions of AP1 (Fos/Jun) in bone development. Annals of the Rheumatic Diseases 2002, 61(Suppl. 2):ii40-ii42.
38. Wang H., Pickel V.M. Dopamine D2 receptors are present in prefrontal cortical afferents and their targets in patches of the rat caudate-putamen nucleus. The Journal of Comparative Neurology 2002, 442:392-404.
39. Webb I.C., Baltazar R.M., Lehman M.N., Coolen L.M. Bidirectional interactions between the circadian and reward systems: is restricted food access a unique zeitgeber?. European Journal of Neuroscience 2009, 30:1739-1748.
40. Yasoshima Y., Sako N., Senba E., Yamamoto T. Acute suppression, but not chronic genetic deficiency, of c-fos gene expression impairs long-term memory in aversive taste learning. PNAS 2006, 103:7106-7111.
41. Zarghooni S., Wunsch J., Bodenbenner M., Bruggmann D., Grando S.A., Schwantes U., Wess J., Kummer W., Lips K.S. Expression of muscarinic and nicotinic acetylcholine receptors in the mouse urothelium. Life Sciences 2007, 80:2308-2313.
42. Zimmer H.G. Catecholamine-induced cardiac hypertrophy: significance of proto-oncogene expression. Journal of Molecular Medicine (Berlin, Germany) 1997, 75:849-859.